1. Reducing Postoperative Ileus

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

4. POI Definitions Consensus Panel (cont)

5. POI Criteria

6. POI Pathophysiology Mechanisms

7. POI Pathophysiology Phases

8. Epidemiology of POI

9. POI Impact

10. Risk Factors for POI

11. Modifiable Risk Factors for POI

12. Risk Factors for POI Surgical Approach

13. Risk Factors for POI Associated With Colon Surgery

14. POI Prophylaxis Perioperative Nutrition

15. POI Prophylaxis Anesthesia Considerations

16. POI Prophylaxis Goals

17. POI Prophylaxis Pharmacologic Agents

18. POI Prophylaxis Meta-analysis in Abdominal Operations

19. POI Prophylaxis Pooled Analysis of Alvimopan Trials

20. POI Prophylaxis Results of Meta-analysis in Abdominal Operations

21. POI Prophylaxis Meta-analysis in Radical Cystectomy

22. ERAS Definition

23. The Impact of ERAS on POI

24. ERAS Components Preoperative

25. ERAS Components Intraoperative

26. ERAS Components Postoperative

27. Adding Alvimopan to ERAS

28. Conclusions

29. Abbreviations